Dear Nebraska Biobank users,
We would like to inform you that the facility remains operational during the pandemic and continues to collect, process, and release samples. There are minor changes to the sample request process due to the anticipated high demand for COVID-19 samples. While we will continue to accept your requests for de-identified DNA, Serum, and Plasma samples per our normal application process, samples that have been collected beginning January 1 until further notice will not be released for non-COVID-19 studies.
The EHR Data Access core is working with our campus informatics, infectious disease, and clinical laboratory professionals to refine how those samples can best be identified in the medical record.
Please be advised that that still leaves nearly 180,000 samples for your non-COVID related research studies. We appreciate your understanding and look forward to continuing to serve your research needs.
Nebraska Biobank Operations Director
The Nebraska Biobank is a Nebraska Research Initiative (NRI) developed joint effort of the University of Nebraska Medical Center (UNMC) and Nebraska Medicine to facilitate research in health care. The Nebraska Biobank is made up of residual blood samples from patients who want to take part.
Patients at the Nebraska Medicine clinics and hospitals are being asked at check-in to participate by donating any blood left from their scheduled laboratory tests to the Nebraska Biobank. Serum, Plasma, and DNA are recovered from the consented samples and stored for future research studies. Deidentified data from the Electronic Health Record (EHR) such as age range, diagnosis, and medications are linked to the stored samples. Any faculty member from the University of Nebraska system may request samples from the biobank for their research projects but all requests are subject to feasibility and scientific merit review.
The Nebraska Biobank also offers sample management services to investigators for clinical trials and registries.